Black Rock Inc. First Wave Bio Pharma, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.46 - $1.15 $3 - $8
-7 Reduced 0.25%
2,788 $2,000
Q3 2022

Nov 14, 2022
BUY
$1.3 - $7.65 $3,633 - $21,381
2,795 New
2,795 $4,000

Others Institutions Holding FWBI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About First Wave BioPharma, Inc.

FWBI Quotes by TradingView
  • Ticker FWBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,562,010
  • Market Cap $2.54M
  • Description
  • First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic ...
More about FWBI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email